Have you heard of the Testa Challenge?

Access to a relevant verification environment in bio production is a limiting factor for many technological and digital innovations.

Raising enough capital to perform a live test in an industrial process can be a challenge for start-ups and researchers, which puts pressure to reach set milestones.

Therefore, at Testa Center, we will open our laboratories this fall for a week, both for academic and commercial innovators in the technical or digital field who would have the potential to increase the efficiency or quality of a bioprocess workflow. This unique challenge allows participants to integrate and verify their innovation in an authentic and validated bioprocess run.

We call this the Testa Challenge and the application period for this event will open very soon.

Start-up’s, academic research groups, major companies and institutes can all apply to Testa Challenge and an external jury will select the projects that are believed to benefit most from participating.

Maybe you or your colleagues want to apply?

The application period opens May 8.

If you have any questions, do not hesitate to contact us to discuss possible technologies to apply with!

Best regards,

The Testa Center team

Sponsors

• 

• 

Are you new to bioproduction?

Find out why this fast-growing market is interesting for you here.

About Testa Center

Testa Center is a non-profit company by Cytiva, formerly GE Healthcare. Co-founded in 2018 by the Swedish agency for innovation, Vinnova, for the growth of the life science industry and its manufacturing capabilities.

Would you like to see the labs? Take a look in at our tour!

We offer businesses and academia globally a modern, pilot-scale testbed for projects and education in production of biological products e.g. monoclonal antibodies, peptides, protein, vaccine and viral vectors (non-GMP, up to Bio-safety level 2 and 500 liter). In our flexible facility, and with some helping hands of our experienced staff, you can perform a wide variety of projects, including scale-up of parts of a process, or a complete process from frozen cell bank vial to purified protein.